Univariate analysis of the results of μCE-based RFLP revealed that the KRAS mutation in codon 12 was not associated with gender, histology, Dukes stage, lymph node and distant metastasis, tumor size, pathological type, and tumor location, but the patients older than 50 years are much more likely to have KRAS mutations. This evidence concerns the gene KRAS and neoplasm.